Mike Matson
Stock Analyst at Needham
(2.27)
# 2,415
Out of 4,818 analysts
505
Total ratings
37.56%
Success rate
-3.84%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Upgrades: Buy | $113 | $95.05 | +18.88% | 28 | Apr 16, 2025 | |
| INMD InMode | Reiterates: Hold | n/a | $15.63 | - | 18 | Apr 14, 2025 | |
| ESTA Establishment Labs Holdings | Initiates: Hold | n/a | $28.78 | - | 1 | Apr 14, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.28 | +134.38% | 18 | Apr 11, 2025 | |
| MASI Masimo | Reiterates: Hold | n/a | $152.07 | - | 25 | Apr 10, 2025 | |
| PSNL Personalis | Reiterates: Buy | $7 | $3.41 | +105.58% | 20 | Apr 10, 2025 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $116 | $91.47 | +26.82% | 25 | Apr 9, 2025 | |
| KIDS OrthoPediatrics | Reiterates: Buy | $42 | $20.78 | +102.12% | 22 | Apr 9, 2025 | |
| ENOV Enovis | Reiterates: Buy | $64 | $32.62 | +96.20% | 14 | Apr 9, 2025 | |
| INGN Inogen | Reiterates: Hold | n/a | $6.75 | - | 18 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4.25 | $2.92 | +45.55% | 17 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $130.68 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $223.02 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $31.97 | +59.52% | 33 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $91.21 | - | 8 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $442 | $348.12 | +26.97% | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $104 | $59.15 | +75.82% | 12 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $35.46 | +80.49% | 25 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $131.44 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $32 | $23.27 | +37.52% | 16 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $31.11 | +63.96% | 16 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $277.22 | - | 10 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $83.37 | - | 17 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $18 | $9.75 | +84.62% | 24 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $97.44 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $58.19 | - | 19 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $91 | $48.02 | +89.50% | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $214.08 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $28.61 | - | 20 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $13.64 | +208.03% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $70.06 | +7.05% | 1 | Feb 18, 2021 |
Boston Scientific
Apr 16, 2025
Upgrades: Buy
Price Target: $113
Current: $95.05
Upside: +18.88%
InMode
Apr 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $15.63
Upside: -
Establishment Labs Holdings
Apr 14, 2025
Initiates: Hold
Price Target: n/a
Current: $28.78
Upside: -
Lucid Diagnostics
Apr 11, 2025
Reiterates: Buy
Price Target: $3
Current: $1.28
Upside: +134.38%
Masimo
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $152.07
Upside: -
Personalis
Apr 10, 2025
Reiterates: Buy
Price Target: $7
Current: $3.41
Upside: +105.58%
Merit Medical Systems
Apr 9, 2025
Reiterates: Buy
Price Target: $116
Current: $91.47
Upside: +26.82%
OrthoPediatrics
Apr 9, 2025
Reiterates: Buy
Price Target: $42
Current: $20.78
Upside: +102.12%
Enovis
Apr 9, 2025
Reiterates: Buy
Price Target: $64
Current: $32.62
Upside: +96.20%
Inogen
Apr 9, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.75
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $4.25
Current: $2.92
Upside: +45.55%
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $130.68
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $223.02
Upside: -
Mar 27, 2025
Reiterates: Buy
Price Target: $51
Current: $31.97
Upside: +59.52%
Mar 26, 2025
Reiterates: Hold
Price Target: n/a
Current: $91.21
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $442
Current: $348.12
Upside: +26.97%
Mar 18, 2025
Maintains: Buy
Price Target: $108 → $104
Current: $59.15
Upside: +75.82%
Mar 17, 2025
Reiterates: Buy
Price Target: $64
Current: $35.46
Upside: +80.49%
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $131.44
Upside: -
Feb 25, 2025
Maintains: Buy
Price Target: $34 → $32
Current: $23.27
Upside: +37.52%
Feb 25, 2025
Reiterates: Buy
Price Target: $51
Current: $31.11
Upside: +63.96%
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $277.22
Upside: -
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $83.37
Upside: -
Feb 19, 2025
Maintains: Buy
Price Target: $19 → $18
Current: $9.75
Upside: +84.62%
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $97.44
Upside: -
Feb 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $58.19
Upside: -
Feb 6, 2025
Maintains: Buy
Price Target: $97 → $91
Current: $48.02
Upside: +89.50%
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $214.08
Upside: -
Jan 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $28.61
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $13.64
Upside: +208.03%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $70.06
Upside: +7.05%